UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-----------------------------
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
-----------------------------
Date of Report (Date of earliest event reported): December 7, 2004
Orthofix International N.V.
(Exact name of Registrant as specified in its charter)
Netherlands Antilles 0-19961 N/A
(State or other jurisdiction (Commission File Number) (I.R.S. Employer Identification
of incorporation) Number)
-----------------------------
7 Abraham de Veerstraat
Curacao
Netherlands Antilles N/A
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: 011-59-99-465-8525
-----------------------------
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2.):
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Principal Officers; Election of
Directors; Appointment of Principal Officers.
As previously announced via a Form 8-K filed on December 8, 2004, Mr.
Kenneth Weishhaar and Mr. Guy Jordan were appointed to the Board on December 7,
2004. As of the date of the filing of a Form 8-K regarding their appointment, no
final decisions had been made with respect to which committees of the Board they
would serve. As of February 11, 2005, Mr. Weishhaar was appointed to the Audit
Committee, the ad hoc International Committee and the Nominating Committee, and
Mr. Jordan was appointed to the Compensation Committee and as the Chair of the
Nominating Committee.
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Dated: February 16, 2005
ORTHOFIX INTERNATIONAL N.V.
By: /s/ Thomas Hein
---------------------------------
Name: Thomas Hein
Title: Chief Financial Officer